Thiel Peter's Form 4 filing
Fractyl Health, Inc.GUTS · filed Feb 8, 2024
- Accession no.
- 0000950170-24-012830
- Filed
- Feb 8, 2024, 4:35 PM ET
- Trade date
- Feb 6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 5 derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thiel PeterCIK 0001211060 | 10% Owner |
| Mithril LPCIK 0001552273 | 10% Owner |
| Mithril II LPCIK 0001669609 | 10% Owner |
| Mithril II UGP LLCCIK 0001878230 | 10% Owner |
| Mithril II GP LPCIK 0001878232 | 10% Owner |
| Mithril GP LPCIK 0001881891 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | CConversionAcquired | +5,160,301 | –F1 | – | 5,160,301 | Direct | |
| Feb 6, 2024 | Common Stock | CConversionAcquired | +918,567 | –F1 | – | 918,567 | Indirect | |
| Feb 6, 2024 | Common Stock | PPurchaseAcquired | +333,333 | $15.00 | +$4,999,995 | 1,251,900 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | CConversionDisposed | −1,875,938 | –F1 | – | 0 | Direct | |
| Feb 6, 2024 | Common Stock | CConversionDisposed | −3,030,193 | –F1 | – | 0 | Direct | |
| Feb 6, 2024 | Common Stock | CConversionDisposed | −254,170 | –F1 | – | 0 | Direct | |
| Feb 6, 2024 | Common Stock | CConversionDisposed | −173,821 | –F1 | – | 0 | Indirect | |
| Feb 6, 2024 | Common Stock | CConversionDisposed | −744,746 | –F1 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock.
Referenced by the price of 2 transactions in Table I and 5 transactions in Table II.